stockchase picture

Compiling comments that experts make about stocks while on public TV.

2012-11-19

Opinion for Abbott Labs (ABT-N)

Signal Price Bias Subject Owned
$62.920 BULLISH NORTH AMERICAN - LARGE Yes

12 drugs under patent after a current one comes off patent.  A hepatitis drug is about to come out as well.  It could hit its 52 week high.

Mohsin Bashir
Associate Portfolio Manager, Highwater Capital Management http://www.highwatercapital.com/

No Comments.


You must be logged in to comment.